FinCanna Capital Corp.

FinCanna Capital Corp.

Our mission is to combine extensive investment expertise, and industry experience in providing growth capital to rapidly emerging private companies operating in the licensed U.S. licensed medical cannabis industry with a focus on California. The Company’s vision is to be the capital partner of choice for rapidly emerging companies focused on the licensed U.S. medical cannabis industry.
1d 5d 1m 6m 1y Max

FinCanna Capital Corp. News

24 May

The FinCanna Capital (CNSX:CALI) Share Price Is Down 70% So Some Shareholders Are Wishing They Sold

Taking the occasional loss comes part and parcel with investing on the stock market. Anyone who held FinCanna Capital...

05 Aug

DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against China Auto Logistics In

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of China Auto Logistics Inc. ("China Auto Logistics" or the "Company")...

02 Aug

MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against China Au

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against China Auto Logistics Inc. (“China Auto Logistics” or ''the Company'') (NASDAQ:...

31 Jul

7-Day Deadline Alert: The Schall Law Firm Announces it is Investigating Claims Against China Auto Logistics

LOS ANGELES, CA / ACCESSWIRE / July 31, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of China Auto Logistics...

26 Jul

China Auto Logistics Inc. Has Been Halted for Trading as Nasdaq Requests Additional Information from the Co

China Auto Logistics Inc. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District...

24 Jul

INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against China Auto Lo

NEW YORK, NY / ACCESSWIRE / July 24, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against China Auto Logistics Inc. ("China Auto" or ...

19 Jul

CALI UPDATE IN FIRST FILED CASE: Rosen Law Firm Updates China Auto Logistics Inc. Investors of Important De

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of China Auto Logistics Inc. from March 28, 2017 through April 13, 2018, both dates inclusive of the upcoming August...

17 Jul

INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against China Auto Lo

NEW YORK, NY / ACCESSWIRE / July 17, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against China Auto Logistics Inc. ("China Auto" or ...

17 Jul

Today's Research Reports on Stocks to Watch: China Auto Logistics and iQIYI

NEW YORK, NY / ACCESSWIRE / July 17, 2018 / Both China Auto Logistics and iQIYI saw their shares gain in Monday's session, and also gave half the gains back in after-hours trading. China Auto Logistics...

10 Jul

CALI ALERT: Pawar Reminds of Important August 6, 2018 Lead Plaintiff Deadline in Class Action - CALI

NEW YORK, NY / ACCESSWIRE / July 10, 2018 / Pawar Law Group reminds shareholders who purchased shares of China Auto Logistics Inc. (NASDAQ: CALI) from March 28, 2017 through April 13, 2018, both dates...

Load more

About FinCanna Capital Corp.

Medical cannabis is becoming legalized rapidly on a global scale, which in turn has driven research initiatives to further discover medicinal benefits. With around 120 trials underway in Israel, the role of medical cannabis is sure to expand as cures and treatments are discovered and proven. [1]

FinCanna is focused on this sector and is confident that its investors and portfolio companies will benefit from this focus.

According to Arcview Market Research and partner BDS Analytics, worldwide spending on legal cannabis is expected to hit $57 billion by 2027. North America will continue to be the leader in legal cannabis buyers, as the $9.2 billion spent in 2017 is expected to grow to $47.3 billion by 2027. [2]

Research at the University of Georgia has found a link between medical cannabis and the decrease in opioid prescriptions in the states that permit dispensaries. The findings show from 2010 to 2015, prescriptions filled for all opioids decreased by 2.11 million. [3] As more cures and treatments are discovered and proven, the role of medical cannabis is sure to expand.

Team

Andriyko Herchak
PRESIDENT & CEO, DIRECTOR
$ 0.20
Open:
0.20
High:
0.20
Low:
0.20
Market cap:
3.388 M
Symbol:
CALI